One of the biggest concerns Farzad Mostashari, MD, chief executive officer of Aledade, has about accountable care organizations, is that they are going to experience backlash similar to what managed care has received in the past.
One of the biggest concerns Farzad Mostashari, MD, chief executive officer of Aledade, has about accountable care organizations (ACOs), is that they are going to experience backlash similar to what managed care has received in the past. It is crucial to reassure all those involved that patients are receiving more and better care while monitoring things like claims data and quality, he said at the National Association of ACOs Spring 2016 Conference.
Transcript (slightly modified)
What concerns do you have about patient backlash to ACOs as they try to provide better quality at lower costs?
You know, you’re The American Journal of Managed Care, and it was founded, I think, in the mid-90s at peak managed care. And since then there’s been kind of this decline in the way managed care is viewed. It became viewed as synonymous (sorry) with gatekeeping, synonymous with people getting less. Not fantastic coordinated, not more accessible and more informed care.
And I think that’s too bad because I do think that there were elements of that that were really fantastic, and I worry that that same backlash is going to hit the next iteration of this new movement.
Yes, we have better data; yes, we have new analytics; yes, we have new technologies; yes, the rules are smarter; yes, quality counts, it’s not just cost. But unless we really reassure our providers, reassure our patients, reassure the public, reassure the policy makers and politicians, that this isn’t “you get less care for less money, this is actually you getting more and better care,” then we face that backlash. And I think one of the things we have to do is we have to have a really robust set of stinting quality measures that you can put together and say, “Hey, look at this. We’re asking a bunch of questions of patients like how easy was it to see a specialist, and did you get the care you needed?”
We’re monitoring claims data, we’re monitoring quality to make sure people don’t skimp on things that maybe cost money now but are going to save people down the line. And we can provide an assurance that these ACOs are successful on reducing cost and not at the cost and benefit of the patient.
Dr Kathy Zackowski Discusses the Importance of Rehabilitation Research and Trials in MS
April 26th 2024Kathy Zackowski, PhD, National MS Society, expresses the inherent value of quality rehabilitation trials for broadening clinical understandings of multiple sclerosis (MS) and bettering patient outcomes.
Read More
Examining Low-Value Cancer Care Trends Amidst the COVID-19 Pandemic
April 25th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the April 2024 issue of The American Journal of Managed Care® about their findings on the rates of low-value cancer care services throughout the COVID-19 pandemic.
Listen
Empowering Community Health Through Wellness and Faith
April 23rd 2024To help celebrate and recognize National Minority Health Month, we are bringing you a special month-long podcast series with our Strategic Alliance Partner, UPMC Health Plan. In the third episode, Camille Clarke-Smith, EdD, MS, CHES, CPT, discusses approaching community health holistically through spiritual and community engagement.
Listen
HOPE-CAT Can Identify Maternal Cardiovascular Risk 2 Months Earlier Than Doctors, Study Says
April 25th 2024In a retrospective study, the machine learning tool was able to screen for potential risks of cardiovascular disease nearly 60 days before the patient's medical record showed any signs of a related condition or before they were officially diagnosed or treated for it.
Read More
Dr Dalia Rotstein: Physicians Must Be Aware MS Affects People of All Backgrounds
April 24th 2024Dalia Rotstein, MD, MPH, emphazises the importance of awareness that multiple sclerosis (MS) impacts patients from various backgrounds as clinicians think through ways to improve access to care and research efforts in MS.
Read More